{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:17:02Z","timestamp":1792318622685,"version":"4.4.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clim.2022.109108","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T03:12:41Z","timestamp":1662347561000},"page":"109108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades"],"prefix":"10.1016","volume":"243","author":[{"given":"Amer","family":"Al-Musa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna","family":"LaBere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109108_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"von Magnus","year":"1959","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.clim.2022.109108_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/v9100283","article-title":"Assessing monkeypox virus prevalence in small mammals at the human\u2013animal interface in the Democratic Republic of the Congo","volume":"9","author":"Doty","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.clim.2022.109108_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4269\/ajtmh.2007.76.757","article-title":"Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak","volume":"76","author":"Hutson","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.clim.2022.109108_bb0020","series-title":"But It\u2019s Not Going Away Anytime Soon","article-title":"Critics say \u201cmonkeypox\u201d is a racist name","author":"Chappell","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0030","first-page":"599","article-title":"Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man","volume":"46","author":"Marennikova","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.clim.2022.109108_bb0035","first-page":"569","article-title":"Human monkeypox","volume":"46","author":"Foster","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.clim.2022.109108_bb0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0050","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109108_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.spid.2004.09.001","article-title":"Monkeypox: a review of the history and emergence in the Western hemisphere","volume":"15","author":"Ligon","year":"2004","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0060","series-title":"Human Monkeypox Infection A Family Cluster in the.pdf [Internet]","author":"Sejvar et al.","year":"2004"},{"key":"10.1016\/j.clim.2022.109108_bb0070","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3201\/eid2608.191387","article-title":"Imported monkeypox, Singapore","volume":"26","author":"Yong","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0075","doi-asserted-by":"crossref","first-page":"1800509","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509","article-title":"Two cases of monkeypox imported to the United Kingdom, September 2018","volume":"23","author":"Vaughan","year":"2018","journal-title":"Euro Surveill."},{"key":"10.1016\/j.clim.2022.109108_bb0080","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of imported monkeypox, Israel, 2018","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0090","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7132e3","article-title":"Epidemiologic and clinical characteristics of monkeypox cases \u2014 United States, May 17\u2013July 22, 2022","volume":"71","author":"Philpott","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clim.2022.109108_bb0095","series-title":"Monkeypox in the U.S.","author":"CDC","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0100","series-title":"2022 Monkeypox Outbreak Global Map","author":"CDC","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0105","article-title":"Monkeypox virus infection in humans across 16 countries \u2014 April\u2013June 2022","volume":"0","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0110","doi-asserted-by":"crossref","first-page":"2200421","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","article-title":"Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022","volume":"27","author":"Antinori","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.clim.2022.109108_bb0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact \u2013 a novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.clim.2022.109108_bb0120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/labinvest.3780373","article-title":"The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis)","volume":"81","author":"Zaucha","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.clim.2022.109108_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.chom.2012.08.007","article-title":"Vaccinia virus egress: actin OUT with ClathrIN","volume":"12","author":"Schmidt","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2022.109108_bb0130","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2020.01637","article-title":"DNA-sensing antiviral innate immunity in poxvirus infection","volume":"11","author":"Lu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virol.2016.07.016","article-title":"Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus","volume":"497","author":"Arndt","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.clim.2022.109108_bb0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fnmol.2018.00480","article-title":"PKR: a kinase to remember","volume":"11","author":"Gal-Ben-Ari","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.clim.2022.109108_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077804","article-title":"Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109108_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virol.2015.02.048","article-title":"Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus","volume":"481","author":"Earl","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.clim.2022.109108_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01042-17","article-title":"Insufficient innate immunity contributes to the susceptibility of the castaneous mouse to orthopoxvirus infection","volume":"91","author":"Earl","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0160","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1128\/JVI.00162-12","article-title":"Lethal monkeypox virus infection of CAST\/EiJ mice is associated with a deficient gamma interferon response","volume":"86","author":"Earl","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008505","article-title":"Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses","volume":"16","author":"Earl","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2022.109108_bb0170","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1128\/JVI.00162-12","article-title":"Lethal monkeypox virus infection of CAST\/EiJ mice is associated with a deficient gamma interferon response","volume":"86","author":"Earl","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01042-17","article-title":"Insufficient innate immunity contributes to the susceptibility of the castaneous mouse to orthopoxvirus infection","volume":"91","author":"Earl","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0180","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1073\/pnas.0800589105","article-title":"Monkeypox virus evades antiviral CD4 + and CD8 + T cell responses by suppressing cognate T cell activation","volume":"105","author":"Hammarlund","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109108_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virol.2013.09.003","article-title":"Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques","volume":"447","author":"Song","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.clim.2022.109108_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1471-4906(03)00032-2","article-title":"Adaptive immune response of V\u03b32V\u03b42 T cells: a new paradigm","volume":"24","author":"Chen","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0195","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015547","article-title":"Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination","volume":"5","author":"Keasey","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109108_bb0205","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/CDLI.12.7.867-872.2005","article-title":"Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American Outbreak","volume":"12","author":"Karem","year":"2005","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2020.01637","article-title":"DNA-sensing antiviral innate immunity in poxvirus infection","volume":"11","author":"Lu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0215","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/biomedicines9070765","article-title":"Battle royale: innate recognition of poxviruses and viral immune evasion","volume":"9","author":"Yu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clim.2022.109108_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015615","article-title":"Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus","volume":"6","author":"Rubins","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109108_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2010.03270.x","article-title":"A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages: TLR-3 activation inhibits HIV infection","author":"Zhou","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2022.109108_bb0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion","volume":"21","author":"Seet","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0235","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1073\/pnas.160027697","article-title":"A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling","volume":"97","author":"Bowie","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109108_bb0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20021652","article-title":"The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense","volume":"197","author":"Harte","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0245","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1096\/fj.09-144733","article-title":"The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon","volume":"24","author":"del Fern\u00e1ndez De Marco","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2022.109108_bb0250","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20071854","article-title":"The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination","volume":"205","author":"Xu","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0255","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1128\/JVI.00304-15","article-title":"Evasion of the innate immune type I interferon system by monkeypox virus","volume":"89","author":"Arndt","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.clim.2022.109108_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035086","article-title":"Elucidating the role of the complement control protein in monkeypox pathogenicity","volume":"7","author":"Hudson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2022.109108_bb0270","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","article-title":"Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation","volume":"176","author":"Liszewski","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0275","doi-asserted-by":"crossref","first-page":"9527","DOI":"10.1128\/JVI.00199-11","article-title":"Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection","volume":"85","author":"Estep","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0280","series-title":"Monkeypox in the U.S.","author":"CDC","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0285","series-title":"Asymptomatic Monkeypox Virus Infections among Male Sexual Health Clinic Attendees in Belgium","author":"Baetselier","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0295","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.clim.2022.109108_bb0305","author":"Monkeypox"},{"key":"10.1016\/j.clim.2022.109108_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0315","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/infdis\/jiab133","article-title":"Clinical and epidemiological findings from enhanced monkeypox surveillance in Tshuapa Province, Democratic Republic of the Congo during 2011-2015","volume":"223","author":"Whitehouse","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the western hemisphere","volume":"350","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0330","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.clim.2022.109108_bb0335","doi-asserted-by":"crossref","first-page":"e0005857","DOI":"10.1371\/journal.pntd.0005857","article-title":"Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo","volume":"11","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0340","author":"Snapshot"},{"key":"10.1016\/j.clim.2022.109108_bb0345","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/505880","article-title":"Clinical manifestations of human monkeypox influenced by route of infection","volume":"194","author":"Reynolds","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0350","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0355","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jix260","article-title":"Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo","volume":"216","author":"Mbala","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0360","first-page":"459","article-title":"Clinico-epidemiological features of monkeypox patients with an animal or human source of infection","volume":"66","author":"Je\u017eek","year":"1988","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.clim.2022.109108_bb0365","author":"Snapshot"},{"key":"10.1016\/j.clim.2022.109108_bb0370","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the western hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0375","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox, and risk factors for severe disease","volume":"41","author":"Huhn","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0385","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3201\/eid1404.071044","article-title":"Retrospective analysis of monkeypox infection","volume":"14","author":"Dubois","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0390","first-page":"867","article-title":"Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin m enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American Outbreak","volume":"12","author":"Karem","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0395","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","article-title":"A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27","volume":"464\u2013465","author":"Hughes","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.clim.2022.109108_bb0400","author":"Monkeypox Rapid Test Kit"},{"key":"10.1016\/j.clim.2022.109108_bb0410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2014.12.001","article-title":"Cytokine modulation correlates with severity of monkeypox disease in humans","volume":"63","author":"Johnston","year":"2015","journal-title":"J. Clin. Virol."},{"issue":"10","key":"10.1016\/j.clim.2022.109108_bb0415","doi-asserted-by":"crossref","first-page":"e0007791","DOI":"10.1371\/journal.pntd.0007791","article-title":"A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy","volume":"13","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0420","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"Stittelaar","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2022.109108_bb0430","author":"PubChem"},{"key":"10.1016\/j.clim.2022.109108_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.clim.2022.109108_bb0440","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0445","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.clim.2022.109108_bb0450","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/CVI.00148-07","article-title":"Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection","volume":"14","author":"Karem","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.clim.2022.109108_bb0455","series-title":"Instructions for Smallpox Vaccination with Bifurcated Needle","year":"1968"},{"key":"10.1016\/j.clim.2022.109108_bb0460","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.vaccine.2017.05.058","article-title":"Comparative efficacy of intramuscular and scarification routes of administration of live smallpox vaccine in a murine challenge model","volume":"35","author":"Phelps","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2022.109108_bb0465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000TM: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.clim.2022.109108_bb0475","series-title":"Selected Discontinued U.S. Vaccines","year":"2011"},{"key":"10.1016\/j.clim.2022.109108_bb0480","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge","volume":"26","author":"Marriott","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2022.109108_bb0485","series-title":"Monkeypox in the U.S. ACAM2000","author":"CDC","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0490","series-title":"Package-Insert---ACAM2000","year":"2007"},{"key":"10.1016\/j.clim.2022.109108_bb0500","series-title":"Severe Eczema Vaccinatum in a Household Contact of a Smallpox Vaccinee","first-page":"1555","volume":"46 (10)","author":"Vora","year":"2008"},{"key":"10.1016\/j.clim.2022.109108_bb0505","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia virus Ankara","author":"Volz","year":"2017"},{"key":"10.1016\/j.clim.2022.109108_bb0510","series-title":"Package Insert - JYNNEOS","year":"2019"},{"key":"10.1016\/j.clim.2022.109108_bb0515","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clim.2022.109108_bb0520","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109108_bb0525","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 efficacy trial of Modified Vaccinia Ankara as a vaccine against smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2022.109108_bb0530","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/infdis\/jit105","article-title":"Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial","volume":"207","author":"Walsh","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0535","article-title":"FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox","author":"Case Medical Research","year":"2019","journal-title":"CMR"},{"key":"10.1016\/j.clim.2022.109108_bb0540","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0545","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/651561","article-title":"Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration","volume":"201","author":"Wilck","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0550","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/651560","article-title":"Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with dryvax","volume":"201","author":"Seaman","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0555","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2015.06.075","article-title":"Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects","volume":"33","author":"Frey","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.clim.2022.109108_bb0560","series-title":"LC16m8 Attenuated Smallpox Vaccine","first-page":"7009","volume":"24(47)","author":"Kenner","year":"2006"},{"key":"10.1016\/j.clim.2022.109108_bb0565","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine."},{"key":"10.1016\/j.clim.2022.109108_bb0570","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2022.109108_bb0575","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2022.109108_bb0580","series-title":"Monkeypox in the U.S.","author":"CDC","year":"2022"},{"key":"10.1016\/j.clim.2022.109108_bb0585","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:06:36Z","timestamp":1761494796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":106,"alternative-id":["S1521661622001899"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109108","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109108"}}